US EditionPublished • loading... • Updated
How STAT's Lizzy Lawrence covers the quickly evolving FDA
Summary by healthjournalism.org
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
How STAT's Lizzy Lawrence covers the quickly evolving FDA
The recent announcement that Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), is leaving the agency — for the second time — is a reminder of how challenging it can be to keep up with the rapid changes at the FDA. At STAT News, Lizzy Lawrence notes in her article about the departure that the Center for Drug Evaluation and Research (CDER), a separate but related department, has had five directors in 2025 alo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
